IRVINE, CA -- (Marketwired) -- 06/26/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that its EPIC 10® diode soft-tissue laser platform won the gold medal for Dental Instruments, Equipment, and Supplies at the 15th Annual Medical Design Excellence Awards ("MDEA"), the MedTech Industry's premier design competition. The award was presented to BIOLASE® at the 2013 MDEA ceremony on Wednesday, June 19, in Philadelphia.
Sponsored by the Medical Device and Diagnostic Industry ("MD+DI") and organized by UBM Canon, the MDEA Program recognizes the achievements of medical device manufacturers, their suppliers, and the many people behind the scenes -- engineers, scientists, designers, and clinicians -- who are responsible for the groundbreaking innovations that are changing the face of healthcare today. Each year a comprehensive evaluation of the entries is performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, clinical practice, diagnostics, human factors, industrial design, manufacturing, and medicine.
Federico Pignatelli, Chairman and CEO, said, "We are honored to receive this recognition for our EPIC 10 diode laser system from the best and brightest medical device designers in the world. This award is the direct result of the dedication and passion of our experienced engineers, designers and product managers and the desire they have to deliver groundbreaking surgical tools that provide better treatment solutions for dentists and their patients. The EPIC 10 platform is FDA-cleared in dentistry and 19 medical markets and represents the next generation of our diode laser technology."
The U.S. Food and Drug Administration ("FDA") cleared the dental EPIC 10 for a wide variety of dental applications on September 28, 2012. The EPIC 10S, the medical version of the diode laser platform, was cleared by the FDA on April 5, 2013, for use as a surgical instrument for over 80 different indications in 19 additional medical markets including: ear, nose and throat, oral surgery, arthroscopy, gastroenterology, orthopedics, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery. The veterinary version of the EPIC diode laser platform, the V-Series, was launched in February 2013.
"Winning this latest MDEA honor, the fourth resulting from our collaboration with Morphix Design, is an affirmation of our commitment to both the doctor and patient experience," said Dmitri Boutoussov, Chief Technology Officer. "The MDEA sets the highest standard for improving the delivery of medical products and services and we are very pleased that the jurors recognized the design of our EPIC platform for its versatility and for the marriage of our advanced laser technology with ease of use for improved patient outcomes."
BIOLASE's diode lasers are currently used in dentistry for a wide variety of surgical soft-tissue procedures as an alternative to invasive and traumatic conventional devices, such as the high-speed drill, scalpel, or electrosurge. The 940nm laser wavelength of the EPIC 10 platform is better absorbed by hemoglobin (Hb) and oxyhemoglobin (HbO2) than other diode laser wavelengths, so it cuts efficiently at low power and with considerably less heat and discomfort, making it an excellent alternative to conventional surgical devices. BIOLASE's EPIC 10 940nm wavelength diode laser uses disposable tips which help reduce the risk of infection and cross contamination and is also FDA cleared for tooth whitening and temporary pain relief.
About the MDEA Program
The 2013 Medical Design Excellence Awards were presented by UBM Canon, the global advanced manufacturing and MedTech authority, and by Medical Device and Diagnostic Industry ("MD+DI"), the industry's central source for late breaking news, information, and business intelligence.
For more information about the MDEA, visit www.MDEAwards.com, or e-mail firstname.lastname@example.org.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase® and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos.
BIOLASE®, WaterLase®, EPIC 10®, EPIC 10S®, EPIC V-Series, and ComfortPulse are registered trademarks or trademarks of BIOLASE, Inc.
Add to Digg Bookmark with del.icio.us Add to Newsvine
For further information, please contact:
Porter, LeVay & Rose, Inc.
Most Popular Stories
- Chinese May Have Spotted Malaysia Airlines Debris
- Why Buffett Bets Big on Green Energy
- 3 Shot Dead in Venezuela Unrest
- Banks Buying Little From Minority Firms: Study
- Better Pay Means Bigger Profits: Strategist
- Several Texas Cities Top Job Search List
- First-time Jobless Claims Drop Unexpectedly
- Senate Committee OKs Bill to Sanction Russia
- G7 Presses Russia to Pull Troops Out of Crimea
- Wall Street Rally Heads Off 3rd Day of Decline